These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17097821)

  • 1. Statins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression.
    Tsai SJ
    Med Hypotheses; 2007; 68(6):1296-9. PubMed ID: 17097821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P11, tPA/plasminogen system and brain-derived neurotrophic factor: Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants.
    Tsai SJ
    Med Hypotheses; 2007; 68(1):180-3. PubMed ID: 16890384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is dysfunction of the tissue plasminogen activator (tPA)-plasmin pathway a link between major depression and cardiovascular disease?
    Hou SJ; Yen FC; Tsai SJ
    Med Hypotheses; 2009 Feb; 72(2):166-8. PubMed ID: 18929445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible role of tissue-type plasminogen activator and the plasminogen system in the pathogenesis of major depression.
    Tsai SJ
    Med Hypotheses; 2006; 66(2):319-22. PubMed ID: 16309851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antidepressive effect of the physical exercise correlates with increased levels of mature BDNF, and proBDNF proteolytic cleavage-related genes, p11 and tPA.
    Sartori CR; Vieira AS; Ferrari EM; Langone F; Tongiorgi E; Parada CA
    Neuroscience; 2011 Apr; 180():9-18. PubMed ID: 21371535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
    Tsai SJ
    Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of the BDNF-dependent pathway in treatment-emergent suicidality or decreased response to antidepressants.
    Tsai SJ
    Med Hypotheses; 2005; 65(5):942-6. PubMed ID: 16002234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment.
    Jiang H; Chen S; Li C; Lu N; Yue Y; Yin Y; Zhang Y; Zhi X; Zhang D; Yuan Y
    Transl Psychiatry; 2017 Apr; 7(4):e1079. PubMed ID: 28375203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
    Kozisek ME; Middlemas D; Bylund DB
    Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system.
    Tang M; Jiang P; Li H; Cai H; Liu Y; Gong H; Zhang L
    Physiol Behav; 2015 Feb; 139():210-5. PubMed ID: 25449400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deltamethrin, a pyrethroid insecticide, could be a potential antidepressant agent.
    Tsai SJ
    Med Hypotheses; 2006; 66(3):605-8. PubMed ID: 16310970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine ameliorates depressive-like behaviors by tPA-mediated conversion of proBDNF to mBDNF in the hippocampus of stressed rats.
    Zhang F; Luo J; Zhu X
    Psychiatry Res; 2018 Nov; 269():646-651. PubMed ID: 30216916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications.
    Tsai SJ
    Med Hypotheses; 2007; 68(4):896-9. PubMed ID: 16919891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(1):145-8. PubMed ID: 17196755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins may act through increasing tissue plasminogen activator/plasmin activity to lower risk of Alzheimer's disease.
    Tsai SJ
    CNS Spectr; 2009 May; 14(5):234-5. PubMed ID: 19407721
    [No Abstract]   [Full Text] [Related]  

  • 16. Hippocampus-specific deletion of tissue plasminogen activator "tPA" in adult mice impairs depression- and anxiety-like behaviors.
    Bahi A; Dreyer JL
    Eur Neuropsychopharmacol; 2012 Sep; 22(9):672-82. PubMed ID: 22377193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential antidepressant properties of cysteamine on hippocampal BDNF levels and behavioral despair in mice.
    Shieh CH; Hong CJ; Huang YH; Tsai SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1590-4. PubMed ID: 18582526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine Withdrawal Increases Brain-Derived Neurotrophic Factor Precursor.
    Bachis A; Campbell LA; Jenkins K; Wenzel E; Mocchetti I
    Neurotox Res; 2017 Oct; 32(3):509-517. PubMed ID: 28776309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does neurotropin-3 have a therapeutic implication in major depression?
    Pae CU; Marks DM; Han C; Patkar AA; Steffens D
    Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of brain-derived neurotrophic factor in the antinociceptive effect of antidepressants in neuropathic pain.
    Tsai SJ
    Med Hypotheses; 2005; 65(3):530-3. PubMed ID: 15905042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.